Nuclear receptors, mitochondria and lipid metabolism
Tóm tắt
Từ khóa
Tài liệu tham khảo
Alaynick, 2007, ERRgamma directs and maintains the transition to oxidative metabolism in the postnatal heart, Cell Metab., 6, 13, 10.1016/j.cmet.2007.06.007
Alberti, 2001, Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice, J. Clin. Invest., 107, 565, 10.1172/JCI9794
Allen, 2006, Halofenate is a selective peroxisome proliferator-activated receptor gamma modulator with antidiabetic activity, Diabetes, 55, 2523, 10.2337/db06-0618
Arany, 2005, Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle, Cell Metab., 1, 259, 10.1016/j.cmet.2005.03.002
Arany, 2007, The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle, Cell Metab., 5, 35, 10.1016/j.cmet.2006.12.003
Barak, 1999, PPAR gamma is required for placental, cardiac, and adipose tissue development, Mol. Cell, 4, 585, 10.1016/S1097-2765(00)80209-9
Barger, 2000, PPAR signaling in the control of cardiac energy metabolism, Trends Cardiovasc. Med., 10, 238, 10.1016/S1050-1738(00)00077-3
Barish, 2005, A nuclear receptor atlas: macrophage activation, Mol. Endocrinol., 19, 2466, 10.1210/me.2004-0529
Barish, 2006, PPAR delta: a dagger in the heart of the metabolic syndrome, J. Clin. Invest., 116, 590, 10.1172/JCI27955
Berger, 2002, The mechanisms of action of PPARs, Annu. Rev. Med., 53, 409, 10.1146/annurev.med.53.082901.104018
Bookout, 2006, Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network, Cell, 126, 789, 10.1016/j.cell.2006.06.049
Carrier, 2004, Estrogen-related receptor alpha (ERRalpha) is a transcriptional regulator of apolipoprotein A-IV and controls lipid handling in the intestine, J. Biol. Chem., 279, 52052, 10.1074/jbc.M410337200
Chawla, 2001, Nuclear receptors and lipid physiology: opening the X-files, Science, 294, 1866, 10.1126/science.294.5548.1866
Chen, 2001, HATs on and beyond chromatin, Curr. Opin. Cell Biol., 13, 218, 10.1016/S0955-0674(00)00200-3
Chen, 2007, Estrogen-related receptor beta/NR3B2 controls epithelial cell fate and endolymph production by the stria vascularis, Dev. Cell, 13, 325, 10.1016/j.devcel.2007.07.011
Chen, 2005, Regulation of mitochondrial respiratory chain structure and function by estrogens/estrogen receptors and potential physiological/pathophysiological implications, Biochim. Biophys. Acta, 1746, 1, 10.1016/j.bbamcr.2005.08.001
Cheng, 2004, Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy, Nat. Med., 10, 1245, 10.1038/nm1116
Claudel, 2001, Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor, Proc. Natl. Acad. Sci. USA, 98, 2610, 10.1073/pnas.041609298
Coward, 2001, 4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor gamma, Proc. Natl. Acad. Sci. USA, 98, 8880, 10.1073/pnas.151244398
Desreumaux, 2001, Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies, J. Exp. Med., 193, 827, 10.1084/jem.193.7.827
Desvergne, 1999, Peroxisome proliferator-activated receptors: nuclear control of metabolism, Endocr. Rev., 20, 649
Dressel, 2003, The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells, Mol. Endocrinol., 17, 2477, 10.1210/me.2003-0151
Dufour, 2007, Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRalpha and gamma, Cell Metab., 5, 345, 10.1016/j.cmet.2007.03.007
Escriva, 2004, The evolution of the nuclear receptor superfamily, Essays Biochem., 40, 11, 10.1042/bse0400011
Evans, 1988, The steroid and thyroid hormone receptor superfamily, Science, 240, 889, 10.1126/science.3283939
Ferre, 2004, The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity, Diabetes, 53, S43, 10.2337/diabetes.53.2007.S43
Flegal, 2002, Prevalence and trends in obesity among US adults, 1999–2000, JAMA, 288, 1723, 10.1001/jama.288.14.1723
Ford, 2005, Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence, Diabetes Care, 28, 1769, 10.2337/diacare.28.7.1769
Forman, 1997, Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta, Proc. Natl. Acad. Sci. USA, 94, 4312, 10.1073/pnas.94.9.4312
Forman, 1995, 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma, Cell, 83, 803, 10.1016/0092-8674(95)90193-0
Fu, 2001, 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells, J. Biol. Chem., 276, 38378, 10.1074/jbc.M105805200
Giguere, 1988, Identification of a new class of steroid hormone receptors, Nature, 331, 91, 10.1038/331091a0
Glass, 2000, The coregulator exchange in transcriptional functions of nuclear receptors, Genes Dev., 14, 121, 10.1101/gad.14.2.121
Greschik, 2004, Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity, J. Biol. Chem., 279, 33639, 10.1074/jbc.M402195200
Greschik, 2002, Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3, Mol. Cell, 9, 303, 10.1016/S1097-2765(02)00444-6
Grundy, 2005, Point: the metabolic syndrome still lives, Clin. Chem., 51, 1352, 10.1373/clinchem.2005.050989
Haffner, 2004, Structure-based design of potent retinoid X receptor alpha agonists, J. Med. Chem., 47, 2010, 10.1021/jm030565g
Handschin, 2007, Skeletal muscle fiber-type switching, exercise intolerance and myopathy in PGC-1alpha muscle-specific knockout animals, J. Biol. Chem., 10.1074/jbc.M704817200
Harris, 1994, Localization of a pioglitazone response element in the adipocyte fatty acid-binding protein gene, Mol. Pharmacol., 45, 439
He, 2003, Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle, Proc. Natl. Acad. Sci. USA, 100, 15712, 10.1073/pnas.2536828100
Herzig, 2001, CREB regulates hepatic gluconeogenesis through the coactivator PGC-1, Nature, 413, 179, 10.1038/35093131
Hevener, 2003, Muscle-specific Pparg deletion causes insulin resistance, Nat. Med., 9, 1491, 10.1038/nm956
Hong, 1999, Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3, J. Biol. Chem., 274, 22618, 10.1074/jbc.274.32.22618
Horowitz, 2000, Effect of endurance training on lipid metabolism in women: a potential role for PPARalpha in the metabolic response to training, Am. J. Physiol. Endocrinol. Metab., 279, E348, 10.1152/ajpendo.2000.279.2.E348
Huss, 2007, The nuclear receptor ERRalpha is required for the bioenergetic and functional adaptation to cardiac pressure overload, Cell Metab., 6, 25, 10.1016/j.cmet.2007.06.005
Janowski, 1996, An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha, Nature, 383, 728, 10.1038/383728a0
Jucker, 2007, PPARdelta activation normalizes cardiac substrate metabolism and reduces right ventricular hypertrophy in congestive heart failure, J. Cardiovasc. Pharmacol., 50, 25, 10.1097/FJC.0b013e31804b4163
Kamei, 2003, PPARgamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity., Proc. Natl. Acad. Sci. USA, 100, 12378, 10.1073/pnas.2135217100
Kelly, 2004, Transcriptional regulatory circuits controlling mitochondrial biogenesis and function, Genes Dev., 18, 357, 10.1101/gad.1177604
Kershaw, 2004, Adipose tissue as an endocrine organ, J. Clin. Endocrinol. Metab., 89, 2548, 10.1210/jc.2004-0395
Kersten, 1999, Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting, J. Clin. Invest., 103, 1489, 10.1172/JCI6223
Kliewer, 1995, A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation, Cell, 83, 813, 10.1016/0092-8674(95)90194-9
Kressler, 2002, The PGC-1-related protein PERC is a selective coactivator of estrogen receptor alpha, J. Biol. Chem., 277, 13918, 10.1074/jbc.M201134200
Lago, 2007, Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials, Lancet, 370, 1129, 10.1016/S0140-6736(07)61514-1
Lalloyer, 2006, The RXR agonist bexarotene improves cholesterol homeostasis and inhibits atherosclerosis progression in a mouse model of mixed dyslipidemia, Arterioscler. Thromb. Vasc. Biol., 26, 2731, 10.1161/01.ATV.0000248101.93488.84
Lee, 2003, Transcriptional repression of atherogenic inflammation: modulation by PPARdelta, Science, 302, 453, 10.1126/science.1087344
Lehman, 2000, Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis, J. Clin. Invest., 106, 847, 10.1172/JCI10268
Lehman, 2002, Transcriptional activation of energy metabolic switches in the developing and hypertrophied heart, Clin. Exp. Pharmacol. Physiol., 29, 339, 10.1046/j.1440-1681.2002.03655.x
Lehmann, 1997, Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway, J. Biol. Chem., 272, 3137, 10.1074/jbc.272.6.3137
Lehmann, 1995, An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma), J. Biol. Chem., 270, 12953, 10.1074/jbc.270.22.12953
Leone, 1999, A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders, Proc. Natl. Acad. Sci. USA, 96, 7473, 10.1073/pnas.96.13.7473
Li, 2005, Distinct mechanisms of glucose lowering by specific agonists for peroxisomal proliferator activated receptor gamma and retinoic acid X receptors, J. Biol. Chem., 280, 38317, 10.1074/jbc.M505853200
Lin, 2002, Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres, Nature, 418, 797, 10.1038/nature00904
Liu, 2002, Mechanism of selective retinoid X receptor agonist-induced hypothyroidism in the rat, Endocrinology, 143, 2880, 10.1210/endo.143.8.8930
Luo, 1997, Placental abnormalities in mouse embryos lacking the orphan nuclear receptor ERR-beta, Nature, 388, 778, 10.1038/42022
Luo, 2003, Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor alpha, Mol. Cell. Biol., 23, 7947, 10.1128/MCB.23.22.7947-7956.2003
Mangelsdorf, 1995, The nuclear receptor superfamily: the second decade, Cell, 83, 835, 10.1016/0092-8674(95)90199-X
Medina-Gomez, 2007, PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism, PLoS Genet., 3, e64, 10.1371/journal.pgen.0030064
Mitsunaga, 2004, Loss of PGC-specific expression of the orphan nuclear receptor ERR-beta results in reduction of germ cell number in mouse embryos, Mech. Dev., 121, 237, 10.1016/j.mod.2004.01.006
Mukherjee, 1997, Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists, Nature, 386, 407, 10.1038/386407a0
Muoio, 2002, Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta, J. Biol. Chem., 277, 26089, 10.1074/jbc.M203997200
Nolte, 1998, Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma, Nature, 395, 137, 10.1038/25931
Norris, 2003, Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones, J. Clin. Invest., 112, 608, 10.1172/JCI17305
Ogawa, 2004, A nuclear receptor corepressor transcriptional checkpoint controlling activator protein 1-dependent gene networks required for macrophage activation, Proc. Natl. Acad. Sci. USA, 101, 14461, 10.1073/pnas.0405786101
Ogilvie, 2004, Activation of the retinoid X receptor suppresses appetite in the rat, Endocrinology, 145, 565, 10.1210/en.2003-0907
Olshansky, 2005, A potential decline in life expectancy in the United States in the 21st century, N. Engl. J. Med., 352, 1138, 10.1056/NEJMsr043743
Peet, 1998, Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha, Cell, 93, 693, 10.1016/S0092-8674(00)81432-4
Puigserver, 2003, Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction, Nature, 423, 550, 10.1038/nature01667
Puigserver, 1998, A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis, Cell, 92, 829, 10.1016/S0092-8674(00)81410-5
Reichardt, 1998, DNA binding of the glucocorticoid receptor is not essential for survival, Cell, 93, 531, 10.1016/S0092-8674(00)81183-6
Repa, 2000, The role of orphan nuclear receptors in the regulation of cholesterol homeostasis, Annu. Rev. Cell Dev. Biol., 16, 459, 10.1146/annurev.cellbio.16.1.459
Rhee, 2003, Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis, Proc. Natl. Acad. Sci. USA, 100, 4012, 10.1073/pnas.0730870100
Rodriguez-Calvo, 2006, PGC-1beta down-regulation is associated with reduced ERRalpha activity and MCAD expression in skeletal muscle of senescence-accelerated mice, J. Gerontol. A Biol. Sci. Med. Sci., 61, 773, 10.1093/gerona/61.8.773
Rosen, 2000, Molecular regulation of adipogenesis, Annu. Rev. Cell Dev. Biol., 16, 145, 10.1146/annurev.cellbio.16.1.145
Rosen, 2001, PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth, J. Biol. Chem., 276, 37731, 10.1074/jbc.R100034200
Roy, 2007, Signature of mitochondria of steroidal hormones-dependent normal and cancer cells: potential molecular targets for cancer therapy, Front. Biosci., 12, 154, 10.2741/2056
Schilling, 2006, Gluconeogenesis: re-evaluating the FOXO1-PGC-1alpha connection, Nature, 443, E10, 10.1038/nature05288
Schopfer, 2005, Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand, Proc. Natl. Acad. Sci. USA, 102, 2340, 10.1073/pnas.0408384102
Schreiber, 2004, The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis, Proc. Natl. Acad. Sci. USA, 101, 6472, 10.1073/pnas.0308686101
Schreiber, 2003, The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha), J. Biol. Chem., 278, 9013, 10.1074/jbc.M212923200
Schug, 2007, Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors, Cell, 129, 723, 10.1016/j.cell.2007.02.050
Shulman, 2005, Retinoid X receptor heterodimers in the metabolic syndrome, N. Engl. J. Med., 353, 604, 10.1056/NEJMra043590
Singh Ahuja, 2001, Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents, Mol. Pharmacol., 59, 765, 10.1124/mol.59.4.765
Sonoda, 2007, PGC-1beta controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis, Proc. Natl. Acad. Sci. USA, 104, 5223, 10.1073/pnas.0611623104
St-Pierre, 2006, Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators, Cell, 127, 397, 10.1016/j.cell.2006.09.024
Tanaka, 2003, Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome, Proc. Natl. Acad. Sci. USA, 100, 15924, 10.1073/pnas.0306981100
Tontonoz, 2003, Liver X receptor signaling pathways in cardiovascular disease, Mol. Endocrinol., 17, 985, 10.1210/me.2003-0061
Villena, 2007, Orphan nuclear receptor estrogen-related receptor alpha is essential for adaptive thermogenesis, Proc. Natl. Acad. Sci. USA, 104, 1418, 10.1073/pnas.0607696104
Wang, 2003, Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity, Cell, 113, 159, 10.1016/S0092-8674(03)00269-1
Wang, 2004, Regulation of muscle fiber type and running endurance by PPARdelta, PLoS Biol., 2, e294, 10.1371/journal.pbio.0020294
Weitzel, 2003, Regulation of mitochondrial biogenesis by thyroid hormone, Exp. Physiol., 88, 121, 10.1113/eph8802506
Willson, 1996, The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones, J. Med. Chem., 39, 665, 10.1021/jm950395a
Willson, 1996, Discovery of ligands for the nuclear peroxisome proliferator-activated receptors, Ann. NY Acad. Sci., 804, 276, 10.1111/j.1749-6632.1996.tb18622.x
Willy, 2004, Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligand, Proc. Natl. Acad. Sci. USA, 101, 8912, 10.1073/pnas.0401420101
Wu, 1999, Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1, Cell, 98, 115, 10.1016/S0092-8674(00)80611-X
Xie, 1999, Constitutive activation of transcription and binding of coactivator by estrogen-related receptors 1 and 2, Mol. Endocrinol., 13, 2151, 10.1210/mend.13.12.0381
Xu, 1999, Molecular recognition of fatty acids by peroxisome proliferator-activated receptors, Mol. Cell, 3, 397, 10.1016/S1097-2765(00)80467-0